These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 16054733)

  • 21. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of antibody persistence between live attenuated and inactivated hepatitis A vaccines].
    Liu HF; Zhang XJ; Zhang JL
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):300-3. PubMed ID: 20077725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on re-immunization with live attenuated hepatitis A vaccine].
    Liu Y; Xu Z; Ouyang P
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):162-4. PubMed ID: 10322791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
    Ren A; Ma J; Feng F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
    J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis A vaccine].
    Mussa GC; Borgione S; Mussa F; Silvestro L
    Minerva Pediatr; 1995 Nov; 47(11):439-44. PubMed ID: 8684338
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protection of adolescents against hepatitis A].
    Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
    Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children.
    Bian GL; Ma R; Dong HJ; Ni HX; Hu FJ; Chen YR; Chen JQ; Zhou SY; Lin YX; Xu GZ
    Vaccine; 2010 Jul; 28(30):4798-801. PubMed ID: 20471440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
    Bovier PA; Bock J; Loutan L; Farinelli T; Glueck R; Herzog C
    J Med Virol; 2002 Dec; 68(4):489-93. PubMed ID: 12376955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Debbag R
    Pediatr Infect Dis J; 2010 Jun; 29(6):568-70. PubMed ID: 20195189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune response to one booster dose of inactivated hepatitis A vaccine in college students].
    Liao Z; Feng XW; Liu XE; Zhou YS; Wen HR; Peng SH; Zhang YX; Xu B; Zhuang H; Chen HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):625-628. PubMed ID: 28651399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.